Biolexis Therapeutics

Funding and NIH signals

• SEC Form D raise Raised $1.6M (Form D filed Jun 3, 2026). SEC Form D 0001914060-26-000001 (Jun 3, 2026)
  Evidence (1 event)

  • Jun 3, 2026 · SEC Form D 0001914060-26-000001
    Name of Issuer: Biolexis Therapeutics Inc.; CIK: 1914060; Address: Lehi, UT; Submission type: D; Filing date: 2026-06-03; Industry Group: Biotechnology; Date of First Sale: 2026-05-20; Types of Securities Offered: Other (Convertible Promissory Notes); Business combination transaction: false; Total Offering Amount: 12000000; Total Amount Sold: 1600000; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals